BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36958195)

  • 1. Vorinostat decrease M2 macrophage polarization through ARID1A
    Hsieh TH; Hsu CY; Wu CW; Wang SH; Yeh CH; Cheng KH; Tsai EM
    Biomed Pharmacother; 2023 May; 161():114500. PubMed ID: 36958195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathology and ARID1A Expression in Endometriosis- Associated Ovarian Carcinoma (EAOC) Carcinogenesis Model with Endometrial Autoimplantation and DMBA Induction.
    Wuyung PE; Rahadiati FB; Tjahjadi H; Salinah S; Kusmardi K; Kodariah R; Wiweko B
    Asian Pac J Cancer Prev; 2021 Feb; 22(2):553-558. PubMed ID: 33639673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ARID1A-mutated ovarian cancers depend on HDAC6 activity.
    Bitler BG; Wu S; Park PH; Hai Y; Aird KM; Wang Y; Zhai Y; Kossenkov AV; Vara-Ailor A; Rauscher FJ; Zou W; Speicher DW; Huntsman DG; Conejo-Garcia JR; Cho KR; Christianson DW; Zhang R
    Nat Cell Biol; 2017 Aug; 19(8):962-973. PubMed ID: 28737768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological correlation of ARID1A status with HDAC6 and its related factors in ovarian clear cell carcinoma.
    Yano M; Katoh T; Miyazawa M; Miyazawa M; Ogane N; Miwa M; Hasegawa K; Narahara H; Yasuda M
    Sci Rep; 2019 Feb; 9(1):2397. PubMed ID: 30787326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HDAC6 is a prognostic biomarker that mediates IL-13 expression to regulate macrophage polarization through AP-1 in oral squamous cell carcinoma.
    Tseng CC; Huang SY; Tsai HP; Wu CW; Hsieh TH
    Sci Rep; 2022 Jun; 12(1):10513. PubMed ID: 35732647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ARID1A pathway in ovarian clear cell and endometrioid carcinoma, contiguous endometriosis, and benign endometriosis.
    Chene G; Ouellet V; Rahimi K; Barres V; Provencher D; Mes-Masson AM
    Int J Gynaecol Obstet; 2015 Jul; 130(1):27-30. PubMed ID: 25912412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer.
    Er TK; Su YF; Wu CC; Chen CC; Wang J; Hsieh TH; Herreros-Villanueva M; Chen WT; Chen YT; Liu TC; Chen HS; Tsai EM
    J Mol Med (Berl); 2016 Jul; 94(7):835-47. PubMed ID: 26920370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for the Relationship Between Endometriosis and Epithelial Ovarian Cancer.
    del Carmen MG
    Obstet Gynecol Surv; 2015 Sep; 70(9):587-95. PubMed ID: 26403563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of a novel model of endometriosis-associated ovarian cancer by transplanting uterine tissue from Arid1a/Pten knockout mice.
    Ono M; Miyamoto T; Asaka R; Uchikawa J; Ando H; Tanaka Y; Shinagawa M; Yokokawa Y; Asaka S; Wang TL; Shih IM; Shiozawa T
    Sci Rep; 2023 May; 13(1):8348. PubMed ID: 37221199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endometriosis-associated ovarian carcinoma (EAOC): an entity distinct from other ovarian carcinomas as suggested by a nested case-control study.
    Erzen M; Rakar S; Klancnik B; Syrjänen K
    Gynecol Oncol; 2001 Oct; 83(1):100-8. PubMed ID: 11585420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone Deacetylase (HDAC) Inhibition Induces IκB Kinase (IKK)-dependent Interleukin-8/CXCL8 Expression in Ovarian Cancer Cells.
    Gatla HR; Zou Y; Uddin MM; Singha B; Bu P; Vancura A; Vancurova I
    J Biol Chem; 2017 Mar; 292(12):5043-5054. PubMed ID: 28167529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the IRE1α/XBP1 Endoplasmic Reticulum Stress Response Pathway in
    Zundell JA; Fukumoto T; Lin J; Fatkhudinov N; Nacarelli T; Kossenkov AV; Liu Q; Cassel J; Hu CA; Wu S; Zhang R
    Cancer Res; 2021 Oct; 81(20):5325-5335. PubMed ID: 34548333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HDAC6 Inhibition Synergizes with Anti-PD-L1 Therapy in ARID1A-Inactivated Ovarian Cancer.
    Fukumoto T; Fatkhutdinov N; Zundell JA; Tcyganov EN; Nacarelli T; Karakashev S; Wu S; Liu Q; Gabrilovich DI; Zhang R
    Cancer Res; 2019 Nov; 79(21):5482-5489. PubMed ID: 31311810
    [No Abstract]   [Full Text] [Related]  

  • 14. The Evolution of Estrogen Receptor Signaling in the Progression of Endometriosis to Endometriosis-Associated Ovarian Cancer.
    Andersen CL; Boisen MM; Sikora MJ; Ma T; Tseng G; Suryawanshi S; Vlad A; Elishaev E; Edwards RP; Oesterreich S
    Horm Cancer; 2018 Dec; 9(6):399-407. PubMed ID: 30302736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ARID1A-deficient cells require HDAC6 for progression of endometrial carcinoma.
    Megino-Luque C; Sisó P; Mota-Martorell N; Navaridas R; de la Rosa I; Urdanibia I; Albertí-Valls M; Santacana M; Pinyol M; Bonifaci N; Macià A; Llobet-Navas D; Gatius S; Matias-Guiu X; Eritja N
    Mol Oncol; 2022 Jun; 16(11):2235-2259. PubMed ID: 35167193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Is endometriosis a precancerous lesion? Perspectives and clinical implications].
    Chene G; Caloone J; Moret S; Le Bail-Carval K; Chabert P; Beaufils E; Mellier G; Lamblin G
    Gynecol Obstet Fertil; 2016 Feb; 44(2):106-12. PubMed ID: 26850282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic Inhibition of Histone Deacetylase 6 Prevents the Progression of Chlorhexidine Gluconate-Induced Peritoneal Fibrosis by Blockade of M2 Macrophage Polarization.
    Shi Y; Li J; Chen H; Hu Y; Tang L; Zhou X; Tao M; Lv Z; Chen S; Qiu A; Liu N
    Front Immunol; 2022; 13():899140. PubMed ID: 35784347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression and significance of GLI1 and Shh in the malignant transformation of ovarian endometriosis].
    Zhao F; Yu XP; Zhao H; Song BB; Lyu AW; Zhang SH; Wang LM
    Zhonghua Fu Chan Ke Za Zhi; 2022 Feb; 57(2):125-132. PubMed ID: 35184473
    [No Abstract]   [Full Text] [Related]  

  • 19. The extracellular vesicular pseudogene LGMNP1 induces M2-like macrophage polarization by upregulating LGMN and serves as a novel promising predictive biomarker for ovarian endometriosis recurrence.
    Sun SG; Guo JJ; Qu XY; Tang XY; Lin YY; Hua KQ; Qiu JJ
    Hum Reprod; 2022 Mar; 37(3):447-465. PubMed ID: 34893848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ARID1A mutations in endometriosis-associated ovarian carcinomas.
    Wiegand KC; Shah SP; Al-Agha OM; Zhao Y; Tse K; Zeng T; Senz J; McConechy MK; Anglesio MS; Kalloger SE; Yang W; Heravi-Moussavi A; Giuliany R; Chow C; Fee J; Zayed A; Prentice L; Melnyk N; Turashvili G; Delaney AD; Madore J; Yip S; McPherson AW; Ha G; Bell L; Fereday S; Tam A; Galletta L; Tonin PN; Provencher D; Miller D; Jones SJ; Moore RA; Morin GB; Oloumi A; Boyd N; Aparicio SA; Shih IeM; Mes-Masson AM; Bowtell DD; Hirst M; Gilks B; Marra MA; Huntsman DG
    N Engl J Med; 2010 Oct; 363(16):1532-43. PubMed ID: 20942669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.